Sava Infond’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,200
Closed -$141K 247
2026
Q1
$141K Hold
1,200
0.02% 199
2025
Q4
$197K Buy
1,200
+1,000
+500% +$157K 0.03% 172
2025
Q3
$26.7K Hold
200
﹤0.01% 211
2025
Q2
$24.9K Hold
200
﹤0.01% 214
2025
Q1
$25.4K Hold
200
﹤0.01% 212
2024
Q4
$28.8K Buy
+200
New +$28.7K 0.01% 210

Other funds holding RGEN

Sava Infond's RGEN Position: Q2 2026 in Review

Sava Infond sold out of Repligen (RGEN) in Q2 2026, closing a stake of 1,200 shares — an estimated $141K sold.

Sava Infond first reported a position in RGEN in Q4 2024 and held it in 6 quarters. The position peaked at $197K in Q4 2025. 64 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Sava Infond reported no remaining Repligen position as of Q2 2026 after selling out during the quarter.
  • Sava Infond sold 1,200 Repligen shares in Q2 2026, an estimated $141K.
  • Sava Infond first reported a position in Repligen in Q4 2024 and held it in 6 quarters.
  • Sava Infond's Repligen position peaked at $197K in Q4 2025.
  • 64 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Sava Infond's 13F filing for Q2 2026, filed 16 Jul 2026.